New Recommendations Guide Arthritis Pain Management

Share this content:
New Recommendations Guide Arthritis Pain Management
New Recommendations Guide Arthritis Pain Management

THURSDAY, June 21, 2018 (HealthDay News) -- The European League Against Rheumatism has released recommendations -- published in the June issue of the Annals of the Rheumatic Diseases -- for health professionals to use in approaching pain management in inflammatory arthritis (IA) and osteoarthritis (OA).

Rinie Geenen, Ph.D., from Utrecht University in the Netherlands, and colleagues on a multidisciplinary task force including professionals and patient representatives conducted a systematic literature review to assess evidence regarding effects on pain of multiple treatment modalities. The authors included 186 reviews in their analysis.

The task force emphasized the importance for the health professional of adopting a patient-centered framework within a biopsychosocial perspective, having sufficient knowledge of IA and OA pathogenesis, and being able to differentiate localized and generalized pain. Pain treatment usually includes education, which can be complemented with physical activity and exercise; orthotics; psychological and social interventions; sleep hygiene education; weight management; pharmacological and joint-specific treatment options; or interdisciplinary pain management. Pain was consistently positively affected by physical activity and exercise interventions as well as psychological interventions.

"Underpinned by available systematic reviews and meta-analyses, these recommendations enable health professionals to provide knowledgeable pain-management support for people with IA and OA," the authors write.

Abstract/Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Salmonella Outbreak in 26 States Linked to Raw Turkey Products

<i>Salmonella</i> Outbreak in 26 States Linked to Raw ...

40 individuals have been hospitalized to date; no deaths have been reported

FDA Recalls Drugs Containing Active Ingredient Valsartan

FDA Recalls Drugs Containing Active Ingredient Valsartan

All lots of non-expired products that contain valsartan supplied by Zhejiang Huahai being recalled

Atopic Dermatitis Places Heavy Burden on Patients

Atopic Dermatitis Places Heavy Burden on Patients

Overall and mental health, life satisfaction all impacted, especially for moderate, severe disease

is free, fast, and customized just for you!




Already a member?

Sign In Now »